Piet N. Post
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Piet N. Post has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anne Margarethe Stiggelbout
Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands
1 shared publication J. Hajo van Bockel
From the Departments of Medical Decision Making (P.N.P., J.K., W.B. van den H.) and Surgery (P.N.P., J.K., J.M. van B., J.H. van B.), Leiden University Medical Center, Leiden, The Netherlands
1 shared publicationJary M. van Baalen
From the Departments of Medical Decision Making (P.N.P., J.K., W.B. van den H.) and Surgery (P.N.P., J.K., J.M. van B., J.H. van B.), Leiden University Medical Center, Leiden, The Netherlands
1 shared publicationJob Kievit
From the Departments of Medical Decision Making (P.N.P., J.K., W.B. van den H.) and Surgery (P.N.P., J.K., J.M. van B., J.H. van B.), Leiden University Medical Center, Leiden, The Netherlands
1 shared publicationPeter P. Wakker
From the Departments of Medical Decision Making (P.N.P., A.M.S., P.P.W.) and Vascular Surgery (P.N.P.), Leiden University Medical Center (Netherlands)
1 shared publication- Wilbert B. van Den Hout
Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands
1 shared publication
Latest Publications
- 1 March 2002
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (3) , 749-755
Routine Duplex Surveillance Does Not Improve the Outcome After Carotid Endarterectomy
Background — Doppler ultrasound (duplex) tests are commonly applied after carotid endarterectomy to detect possible recurrent stenosis. The appropriate frequency and the benefits are unknown. We investigated the costs and effects of various follow-up strategies to determine the optimal strategy after carotid endarterectomy. Methods — Using decision-analytic methods, a Monte Carlo Markov model was constructed. Probabilities and costs were obtained by systematic literature review. From empirical data regarding restenosis, a disease model was constructed to test the effect of various follow-up strategies using duplex testing and angiography. Main outcome measures were quality-adjusted life-years (QALYs), probability of stroke, and costs (for both the Dutch and the American situation). Results — The average quality-adjusted life expectancy for a 66-year-old patient was 6.31 years for the symptom-guided strategy (with duplex scanning only being performed in case of symptoms of cerebral ischemia). The mean lifetime costs for this strategy were $5 600 for the US and 4 600 Euro for the Netherlands. The cumulative probability of stroke was 13%. Yearly routine duplex tests up to 5 years after operation resulted in similar QALYs and a similar probability of stroke, but higher costs ($7 300 for the US and 5 600 Euro for The Netherlands situation). No other strategy, including routine duplex surveillance, increased QALYs. When MR instead of conventional angiography was used as confirmatory test, no improvement was observed either. Conclusions — Routine duplex surveillance does not result in an increase in quality-adjusted life expectancy, but it does increase costs. After successful carotid endarterectomy, a symptom-guided follow-up is an appropriate approach.
- 1 March 2002
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (3) , 749-755
Routine Duplex Surveillance Does Not Improve the Outcome After Carotid Endarterectomy
Background — Doppler ultrasound (duplex) tests are commonly applied after carotid endarterectomy to detect possible recurrent stenosis. The appropriate frequency and the benefits are unknown. We investigated the costs and effects of various follow-up strategies to determine the optimal strategy after carotid endarterectomy. Methods — Using decision-analytic methods, a Monte Carlo Markov model was constructed. Probabilities and costs were obtained by systematic literature review. From empirical data regarding restenosis, a disease model was constructed to test the effect of various follow-up strategies using duplex testing and angiography. Main outcome measures were quality-adjusted life-years (QALYs), probability of stroke, and costs (for both the Dutch and the American situation). Results — The average quality-adjusted life expectancy for a 66-year-old patient was 6.31 years for the symptom-guided strategy (with duplex scanning only being performed in case of symptoms of cerebral ischemia). The mean lifetime costs for this strategy were $5 600 for the US and 4 600 Euro for the Netherlands. The cumulative probability of stroke was 13%. Yearly routine duplex tests up to 5 years after operation resulted in similar QALYs and a similar probability of stroke, but higher costs ($7 300 for the US and 5 600 Euro for The Netherlands situation). No other strategy, including routine duplex surveillance, increased QALYs. When MR instead of conventional angiography was used as confirmatory test, no improvement was observed either. Conclusions — Routine duplex surveillance does not result in an increase in quality-adjusted life expectancy, but it does increase costs. After successful carotid endarterectomy, a symptom-guided follow-up is an appropriate approach.
- 1 June 2001
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (6) , 1425-1429
The Utility of Health States After Stroke
Background—To perform decision analyses that include stroke as one of the possible health states, the utilities of stroke states must be determined. We reviewed the literature to obtain estimates of the utility of stroke and explored the impact of the study population and the elicitation method.Summary of Review—We searched various databases for articles reporting empirical assessment of utilities. Mean utilities of major stroke (Rankin Scale 4 to 5) and minor stroke (Rankin Scale 2 to 3) were calculated, stratified by study population and elicitation method. Additionally, the modified Rankin Scale was mapped onto the EuroQol classification system. Utilities were obtained from 23 articles. Patients at risk for stroke assigned utilities of 0.26 and 0.55 to major and minor stroke, respectively. Stroke survivors assigned higher utilities to both major (0.41) and minor stroke (0.72). The EuroQol completed by stroke survivors revealed a utility of 0.32 and 0.71 for major and minor stroke, respectively. Utilities elicited by the Standard Gamble were generally higher, while those obtained by the Visual Analogue Scale were lower than the Time Trade Off values. Remaining variation between utilities may be caused by differences in definitions of the health states. The mapped EuroQol indicated a utility of 0.64 for minor stroke and a value just below zero for major stroke.Conclusions—For minor stroke, a utility between 0.50 and 0.70 seems to be reasonable for both decision analyses and cost-effectiveness studies. The utility of major stroke may range between 0 and 0.30 and may possibly be negative.
- 1 June 2001
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (6) , 1425-1429
The Utility of Health States After Stroke
Background—To perform decision analyses that include stroke as one of the possible health states, the utilities of stroke states must be determined. We reviewed the literature to obtain estimates of the utility of stroke and explored the impact of the study population and the elicitation method.Summary of Review—We searched various databases for articles reporting empirical assessment of utilities. Mean utilities of major stroke (Rankin Scale 4 to 5) and minor stroke (Rankin Scale 2 to 3) were calculated, stratified by study population and elicitation method. Additionally, the modified Rankin Scale was mapped onto the EuroQol classification system. Utilities were obtained from 23 articles. Patients at risk for stroke assigned utilities of 0.26 and 0.55 to major and minor stroke, respectively. Stroke survivors assigned higher utilities to both major (0.41) and minor stroke (0.72). The EuroQol completed by stroke survivors revealed a utility of 0.32 and 0.71 for major and minor stroke, respectively. Utilities elicited by the Standard Gamble were generally higher, while those obtained by the Visual Analogue Scale were lower than the Time Trade Off values. Remaining variation between utilities may be caused by differences in definitions of the health states. The mapped EuroQol indicated a utility of 0.64 for minor stroke and a value just below zero for major stroke.Conclusions—For minor stroke, a utility between 0.50 and 0.70 seems to be reasonable for both decision analyses and cost-effectiveness studies. The utility of major stroke may range between 0 and 0.30 and may possibly be negative.